Strem Brian M. 4

What Happened

• Brian Strem, President & CEO and Director of Kiora Pharmaceuticals (KPRX), had 238 shares withheld to satisfy employee tax obligations upon vesting of restricted stock. The filing shows a per-share value of $2.02, for a total of $481. The transaction is reported as a disposition via tax withholding (code F) and noted as a net share settlement.

Key Details

• Transaction date: 2026-03-03; Form 4 filed: 2026-03-06
• Shares withheld/disposed: 238 at $2.02 each; total value reported: $481
• Transaction code: F (tax withholding / net share settlement on vesting)
• Remark in filing: shares withheld for employee tax obligation upon vesting of restricted stock
• Shares owned after transaction: not specified in the provided filing summary

Context

• This was a tax-withholding/net-settlement on vested restricted stock — a routine administrative disposition rather than an open-market sale or purchase. Such withholdings are common and typically do not signal a change in insider sentiment; the dollar amount here is small.